Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BRD5648 ((R)-BRD0705) is an inactive (R)-enantiomer of BRD0705. BRD0705 is a GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM) and can be used in acute myeloid leukemia (AML) studies.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
無料サンプル 1 mg | |||||
1 mg | 在庫あり | ¥ 24,500 | |||
5 mg | 在庫あり | ¥ 56,000 | |||
10 mg | 在庫あり | ¥ 82,500 | |||
25 mg | 在庫あり | ¥ 137,500 | |||
50 mg | 在庫あり | ¥ 196,000 | |||
100 mg | 在庫あり | ¥ 271,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 59,500 |
説明 | BRD5648 ((R)-BRD0705) is an inactive (R)-enantiomer of BRD0705. BRD0705 is a GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM) and can be used in acute myeloid leukemia (AML) studies. |
別名 | (R)-BRD0705 |
分子量 | 321.42 |
分子式 | C20H23N3O |
CAS No. | 2056261-42-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 300 mg/mL (933.36 mM), sonification is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BRD5648 2056261-42-6 PI3K/Akt/mTOR signaling Stem Cells GSK-3 compound Glycogen synthase kinase 3 BRD0705 BRD 0705 (R)-BRD0705 BRD-0705 negative Glycogen synthase kinase-3 BRD-5648 BRD 5648 inhibit Inhibitor (R)-enantiomer control inhibitor